The Cooper Companies, Inc.

NASDAQ:COO

Medical - Instruments & Supplies

Healthcare
$60.75 -3.42%

-$2.30 today

Market cap
$11.55B
Beta
0.87
P/E (TTM)
53.8
EPS (TTM)
$1.21
52W Low $58.89High $89.83

Volume 2.20M

Average 2.55M

COO EPS (Diluted)

Earnings per share assuming conversion of dilutive securities such as options and convertible instruments.

The Cooper Companies, Inc.NASDAQ: COO

EPS (Diluted) · Q3 FY2026 · quarter ended Jul 2026

EPS (Diluted) growth accelerates

Q3 FY2026 EPS (Diluted) of $2.24 rose 357.1% year over year, ahead of the +44.3% change in trailing-twelve-month EPS (Diluted). Over 3 fiscal years it compounded at -1.2% a year.

Context

  • EPS (Diluted) increased in 1 of the last 3 fiscal years.

What to watch

Whether EPS (Diluted) reaches the consensus estimate from 11 analysts of $4.53 (+142.3%) for the fiscal year ending Oct 2026, a step up from the -4.6% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJul 2026
$2.24+660.0% QoQ
Last fiscal yearOct 2025
$1.87-4.6% YoY
LTMJul 2026
$2.93+44.3% YoY
EPS (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+357.1%+148.5%-208.7 pp
1 year-4.6%+142.3%+146.9 pp
3-year CAGR-1.2%+39.6%+40.8 pp
5-year CAGR+26.8%—
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EPS (Diluted) history

USD · from the income statement

Latest · FY2025
1.87 USD
Year-over-year change
-4.6%
4-year CAGR
-40.4%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EPS (Diluted) vs competitors

How COO compares with its peers on the latest reported figures

  • COO's LTM Jul 2026 EPS (Diluted) of $2.93 is the highest of the 6 companies compared; the peer median is -$0.48.
  • Its year-over-year change of +44.3% is the 3rd highest of 6, against a peer median of +38.5%.
  • Over three fiscal years its annual growth of -1.2% compares with a peer median of +42.8%.
COO Competitors Peer median
EPS (Diluted) for COO and competitors
Company Period LTM YoY 3-year CAGR
COOThe Cooper Companies, Inc.LTM Jul 2026$2.93 +44.3%-1.2%
ALCAlcon Inc.LTM Sep 2026$1.36 -35.2%+42.8%
STAASTAAR Surgical CompanyLTM Apr 2026-$0.42 +70.8%—
BLCOBausch + Lomb CorporationLTM Jun 2026-$0.48 +38.5%—
LNSRLENSAR, Inc.LTM Mar 2026-$0.58 +88.1%—
GKOSGlaukos CorporationLTM Jun 2026-$3.25 -97.0%—
Peer median (excluding COO) -$0.48+38.5%+42.8%

Competitors are the stored peer set for COO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Oct 2021
FY2022
Oct 2022
FY2023
Oct 2023
FY2024
Oct 2024
FY2025
Oct 2025
Revenue2.92B3.31B3.59B3.9B4.09B
Cost of Revenue966.7M1.17B1.24B1.3B1.61B
Gross Profit1.96B2.14B2.36B2.6B2.48B
Gross Margin66.9%64.7%65.6%66.6%60.7%
Research & Development92.7M110.3M137.4M155.1M172.2M
Selling, General & Admin1.21B1.34B1.5B1.53B1.63B
Operating Expenses1.45B1.63B1.82B1.89B1.8B
Depreciation & Amortization309.3M346.1M367.7M375.1M423M
EBITDA823.9M878.7M885.9M1.07B1.05B
EBITDA Margin28.2%26.6%24.7%27.5%25.7%
Operating Income505.8M507.6M533.1M705.7M682.9M
Operating Margin17.3%15.3%14.8%18.1%16.7%
Interest Income00000
Interest Expense23.1M57.3M105.3M114.3M100M
Other Income / Expenses(14.3M)(32.3M)(120.2M)(123.4M)(116.4M)
Income Before Tax491.5M475.3M412.9M582.3M566.5M
Pre-Tax Margin16.8%14.4%11.5%14.9%13.8%
Income Tax Expense(2.45B)89.5M118.7M190M191.6M
Net Income2.94B385.8M294.2M392.3M374.9M
Net Margin100.8%11.7%8.2%10.1%9.2%
EPS (Basic)14.931.961.491.971.88
EPS (Diluted)14.791.941.481.961.87
Weighted Avg Shares197.2M197.2M198M198.9M200M
Weighted Avg Shares (Diluted)199.4M198.8M199.2M200.4M200M

The Cooper Companies, Inc.

NASDAQ:COO

Intrinsic Alpha fair value

Locked

Current Price

$60.75

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.